ConforMIS???s customized iTotal CR knee replacements Study
Bedford, Mass. ?????August 3, 2015???????ConforMIS, Inc. (NASDAQ: CFMS) announced today results from six clinical studies presented at the 2015 Pan Pacific International Congress for Joint Reconstruction (ICJR). In an ongoing, blinded, US multicenter study, the investigators reported that patients with customized ConforMIS iTotal CR knee replacements were … Read the Rest